![](/img/cover-not-exists.png)
O-17 Borderline HER2 protein positive breast cancers have similar patient outcome regardless of HER2 gene amplification status
F.F.T. Barros, M. Aleskandarany, E. Rakha, S.L. Watts, D.G. Powe, I.O. Ellis, A.R. GreenVolume:
8
Year:
2010
Language:
english
DOI:
10.1016/j.ejcsup.2010.06.018
File:
PDF, 41 KB
english, 2010